90 related articles for article (PubMed ID: 11155666)
21. E-cadherin expression in early gastric carcinoma and correlation with lymph node metastasis.
Yi Kim D; Kyoon Joo J; Kyu Park Y; Yeob Ryu S; Soo Kim H; Kyun Noh B; Hwa Lee K; Hyuk Lee J
J Surg Oncol; 2007 Oct; 96(5):429-35. PubMed ID: 17786966
[TBL] [Abstract][Full Text] [Related]
22. The angiogenic switch for vascular endothelial growth factor (VEGF)-A, VEGF-B, VEGF-C, and VEGF-D in the adenoma-carcinoma sequence during colorectal cancer progression.
Hanrahan V; Currie MJ; Gunningham SP; Morrin HR; Scott PA; Robinson BA; Fox SB
J Pathol; 2003 Jun; 200(2):183-94. PubMed ID: 12754739
[TBL] [Abstract][Full Text] [Related]
23. [Expression of osteopontin mRNA and its clinical significance in gastric cancer].
Sun XJ; Zuo WS; Ma H; Hou WH; Cai SP; Jiang XH
Zhonghua Zhong Liu Za Zhi; 2005 May; 27(5):292-5. PubMed ID: 15996323
[TBL] [Abstract][Full Text] [Related]
24. Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis.
Sun WH; Sun YL; Fang RN; Shao Y; Xu HC; Xue QP; Ding GX; Cheng YL
Jpn J Clin Oncol; 2005 Dec; 35(12):707-13. PubMed ID: 16314343
[TBL] [Abstract][Full Text] [Related]
25. [mRNA expression of syndecan-1 and heparanase in relation to tumor progression and prognosis of gastric carcinoma].
Ru GQ; Zhao ZS; Tang QL; Xu WJ
Zhonghua Wai Ke Za Zhi; 2006 Aug; 44(15):1062-4. PubMed ID: 17074248
[TBL] [Abstract][Full Text] [Related]
26. High expression of PRL-3 can promote growth of gastric cancer and exhibits a poor prognostic impact on patients.
Wang Z; Cai SR; He YL; Zhan WH; Chen CQ; Cui J; Wu WH; Wu H; Song W; Zhang CH; Peng JJ; Huang XH
Ann Surg Oncol; 2009 Jan; 16(1):208-19. PubMed ID: 19009246
[TBL] [Abstract][Full Text] [Related]
27. Cytoplasmic CD24 expression is a novel prognostic factor in diffuse-type gastric adenocarcinoma.
Chou YY; Jeng YM; Lee TT; Hu FC; Kao HL; Lin WC; Lai PL; Hu RH; Yuan RH
Ann Surg Oncol; 2007 Oct; 14(10):2748-58. PubMed ID: 17680316
[TBL] [Abstract][Full Text] [Related]
28. [Relationship between heparanase mRNA expression in human gastric cancer and its clinicopathological features].
Chen JQ; Zhan WH; He YL; Peng JS; Wang JP; Chen ZX; Huang YH; Cai SR
Zhonghua Zhong Liu Za Zhi; 2004 Oct; 26(10):609-11. PubMed ID: 15634522
[TBL] [Abstract][Full Text] [Related]
29. Re-expression of the cadherin-catenin complex in lymph nodes with metastasis in advanced gastric cancer: the relationship with patient survival.
Liu J; Ikeguchi M; Nakamura S; Kaibara N
J Exp Clin Cancer Res; 2002 Mar; 21(1):65-71. PubMed ID: 12071532
[TBL] [Abstract][Full Text] [Related]
30. Tissue factor expression is a clinical indicator of lymphatic metastasis and poor prognosis in gastric cancer with intestinal phenotype.
Yamashita H; Kitayama J; Ishikawa M; Nagawa H
J Surg Oncol; 2007 Mar; 95(4):324-31. PubMed ID: 17066404
[TBL] [Abstract][Full Text] [Related]
31. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
32. Overexpression of protein kinase Calpha mRNA may be an independent prognostic marker for gastric carcinoma.
Lin KY; Fang CL; Uen YH; Chang CC; Lou HY; Hsieh CR; Tiong C; Pan S; Chen SH
J Surg Oncol; 2008 May; 97(6):538-43. PubMed ID: 18314869
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of insulin-like growth factor II mRNA-binding protein 3 expression in gastric adenocarcinoma.
Jeng YM; Wang TH; Lu SH; Yuan RH; Hsu HC
Br J Surg; 2009 Jan; 96(1):66-73. PubMed ID: 19109797
[TBL] [Abstract][Full Text] [Related]
34. Diffuse expression of hRFI is correlated with blood vessel invasion in gastric carcinoma.
Sasaki S; Kitayama J; Watanabe T; Konishi T; Nagawa H
Jpn J Clin Oncol; 2004 Oct; 34(10):584-7. PubMed ID: 15591455
[TBL] [Abstract][Full Text] [Related]
35. [Correlation of tissue factor expression to angiogenesis of gastric carcinoma and its clinical significance].
Jiao ZY; Gou CZ; Cao N; Li YM
Ai Zheng; 2005 Jul; 24(7):880-4. PubMed ID: 16004820
[TBL] [Abstract][Full Text] [Related]
36. [Expression and significance of cell cycle regulators in gastric carcinoma].
Wu JF; Shao JC; Wang DB; Qin R; Zhang H
Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
[TBL] [Abstract][Full Text] [Related]
37. Prediction of sites of recurrence in gastric carcinoma using immunohistochemical parameters.
Saito H; Osaki T; Murakami D; Sakamoto T; Kanaji S; Ohro S; Tatebe S; Tsujitani S; Ikeguchi M
J Surg Oncol; 2007 Feb; 95(2):123-8. PubMed ID: 17262742
[TBL] [Abstract][Full Text] [Related]
38. Clinical and biological significance of S-phase kinase-associated protein 2 (Skp2) gene expression in gastric carcinoma: modulation of malignant phenotype by Skp2 overexpression, possibly via p27 proteolysis.
Masuda TA; Inoue H; Sonoda H; Mine S; Yoshikawa Y; Nakayama K; Nakayama K; Mori M
Cancer Res; 2002 Jul; 62(13):3819-25. PubMed ID: 12097295
[TBL] [Abstract][Full Text] [Related]
39. Increased expression of galectin-3 in primary gastric cancer and the metastatic lymph nodes.
Miyazaki J; Hokari R; Kato S; Tsuzuki Y; Kawaguchi A; Nagao S; Itoh K; Miura S
Oncol Rep; 2002; 9(6):1307-12. PubMed ID: 12375039
[TBL] [Abstract][Full Text] [Related]
40. Alternative messenger RNA splicing and enzyme forms of cathepsin B in human osteoarthritic cartilage and cultured chondrocytes.
Berardi S; Lang A; Kostoulas G; Hörler D; Vilei EM; Baici A
Arthritis Rheum; 2001 Aug; 44(8):1819-31. PubMed ID: 11508434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
